Hoskins L C, Boulding E T
J Clin Invest. 1976 Jan;57(1):74-82. doi: 10.1172/JCI108271.
The autosomal dominant ABH secretor gene together with the ABO blood type gene control the presence and specificity of A, B, and H blood group antigens in human gut mucin glycoproteins. Certain obligate anaerobes in feces produce extracellular antigen-specific glycoside structures. We estimated the populations of these bacteria in feces of 22 healthy subjects by determining the greatest dilution of feces that yielded A, B, or H blood group-degrading enzyme activity after 24 h incubation in anaerobic cultures. Comparatively small populations of fecal bacteria produce blood group-degrading enzymes; their estimated populations were 10(8) per g or less in 21 subjects. Fecal populations of B-degrading bacteria were stable over time, and their population density averaged 50,000-fold greater in blood group B secretros than in other subjects. We present evidence that the greater fecal populations of B-degrading bacteria in B secretors is due in part to a competitive nutritional advantage gained by their ability to enzymatically cleave the B antigenic determinant alpha-D-galactose from gut mucins of B secretors. Fecal populations of bacteria producing A and H antigen-degrading enzyme activities were comparable in all subjects to the fecal population of B-degrading bacteria in B secretors. The large populations of fecal anaerobes may be an additional source of A antigen substrate for A-degrading bacteria; thus, antigens cross-reacting with A antigen were detected on cell walls of anaerobic bacteria from 3 of 10 cultures inoculated with 10(-10) g feces. Bacteria producing B-degrading activity likely represent a separate population from those producing A- or H-degrading activity since their fecal populations differed numerically in 14 subjects. These findings suggest that adaptation of blood group-degrading enzymes to mucin structures in human colon ecosystems is chiefly by mutation-selection of comparatively small populations of constitutive enzyme-producing strains rather than by substrate induced enzyme synthesis in many strains.
常染色体显性ABH分泌基因与ABO血型基因共同控制人类肠道粘蛋白糖蛋白中A、B和H血型抗原的存在与特异性。粪便中的某些专性厌氧菌可产生细胞外抗原特异性糖苷结构。我们通过测定在厌氧培养中孵育24小时后能产生A、B或H血型降解酶活性的粪便最大稀释度,来估计22名健康受试者粪便中这些细菌的数量。产生血型降解酶的粪便细菌数量相对较少;在21名受试者中,其估计数量为每克10⁸或更少。降解B型的粪便细菌数量随时间稳定,其种群密度在B血型分泌者中平均比其他受试者高50000倍。我们提供的证据表明,B分泌者中降解B型的粪便细菌数量较多,部分原因是它们能够从B分泌者的肠道粘蛋白中酶解B抗原决定簇α-D-半乳糖,从而获得竞争性营养优势。在所有受试者中,产生A和H抗原降解酶活性的粪便细菌数量与B分泌者中降解B型的粪便细菌数量相当。大量的粪便厌氧菌可能是降解A型细菌的A型抗原底物的额外来源;因此,在用10⁻¹⁰克粪便接种的10个培养物中,有3个培养物的厌氧菌细胞壁上检测到了与A型抗原交叉反应的抗原。产生B型降解活性的细菌可能与产生A型或H型降解活性的细菌属于不同种群,因为在14名受试者中它们的粪便数量在数值上有所不同。这些发现表明,血型降解酶对人类结肠生态系统中粘蛋白结构的适应性,主要是通过对相对少量组成型产酶菌株的突变选择,而不是通过许多菌株中底物诱导的酶合成。